ID30032A - Formulasi farmasi - Google Patents

Formulasi farmasi

Info

Publication number: ID30032A
Authority: ID; Indonesia
Prior art keywords: pharmaceutical formulation; formulation; pharmaceutical
Prior art date: 1998-12-15

Application number

IDW00200101527A

Other languages

English (en)

Inventor

Terrence C Dahl

Lung-Chi J Yuan

Original Assignee

Gilead Sciences Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-12-15

Filing date

1999-12-14

Publication date

2001-11-01

1998-12-15 Priority claimed from US09/211,613 external-priority patent/US6635278B1/en

1999-12-14 Application filed by Gilead Sciences Inc filed Critical Gilead Sciences Inc

2001-11-01 Publication of ID30032A publication Critical patent/ID30032A/id

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Inorganic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Virology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

IDW00200101527A 1998-12-15 1999-12-14 Formulasi farmasi ID30032A (id)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US11240398P	1998-12-15	1998-12-15
US09/211,613 US6635278B1 (en)	1998-12-15	1998-12-15	Pharmaceutical formulations

Publications (1)

Publication Number	Publication Date
ID30032A true ID30032A (id)	2001-11-01

Family

ID=26809911

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IDW00200101527A ID30032A (id)	1998-12-15	1999-12-14	Formulasi farmasi

Country Status (18)

Country	Link
EP (1)	EP1140114B1 (id)
JP (1)	JP4750946B2 (id)
KR (1)	KR100624214B1 (id)
CN (2)	CN1202829C (id)
AR (1)	AR021670A1 (id)
AT (1)	ATE298576T1 (id)
AU (1)	AU759869B2 (id)
BR (1)	BRPI9916820B8 (id)
CA (1)	CA2355239C (id)
CO (1)	CO5261557A1 (id)
DE (1)	DE69926012T2 (id)
ES (1)	ES2245130T3 (id)
ID (1)	ID30032A (id)
MY (1)	MY126526A (id)
NZ (1)	NZ511855A (id)
TR (1)	TR200101746T2 (id)
TW (1)	TWI230618B (id)
WO (1)	WO2000035460A2 (id)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2001282941C1 (en) *	2000-07-21	2016-12-22	Gilead Sciences, Inc.	Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same
EP1522539B1 (en) *	2001-07-31	2007-01-24	H. Lundbeck A/S	Crystalline composition containing escitalopram
KR101101962B1 (ko)	2002-11-12	2012-01-02	티안진 디실리 인베스트먼트 홀딩 그룹, 리미티드	새로운 결정 형태를 가진 아데포비어 디피복실의 제조 방법
EP1635847B1 (en)	2003-06-13	2019-07-31	IDH Holding ApS	Treatment of symptoms associated with bacterial vaginosis
ITMI20071594A1 (it)	2007-08-02	2009-02-03	Solmag Spa	Forma cristallina monoidrata di adefovir dipivoxil
KR20100031045A (ko)	2008-09-11	2010-03-19	씨제이제일제당 (주)	아데포비어 디피복실의 정제방법
WO2010032958A2 (ko)	2008-09-17	2010-03-25	씨제이제일제당 (주)	아데포비어 디피복실의 안정화된 고체 분산체 및 이의 제조 방법
KR101089620B1 (ko) *	2009-07-20	2011-12-06	경희대학교 산학협력단	무수결정형 아데포비어 디피복실 및 이온성 액체를 사용한 이의 제조 방법
EP2343056A1 (en)	2009-12-30	2011-07-13	Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi	Producing stable adefovir dipivoxil solid dispersions
KR102662228B1 (ko)	2015-03-04	2024-05-02	머크 샤프 앤드 돔 코포레이션	암을 치료하기 위한 pd-1 길항제 및 vegfr/fgfr/ret 티로신 키나제 억제제의 조합
EP3393468B1 (en) *	2015-12-22	2022-09-14	X4 Pharmaceuticals, Inc.	Methods for treating immunodeficiency disease

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS58201726A (ja) *	1982-05-18	1983-11-24	Meiji Seika Kaisha Ltd	安定な製剤の製造法
CS263952B1 (en) *	1985-04-25	1989-05-12	Holy Antonin	Remedy with antiviral effect
US4704365A (en) *	1986-02-24	1987-11-03	Abbott Laboratories	Composition and method for stabilization of dinucleotides
CA2035841C (en) *	1990-02-22	1996-02-13	Harry B. Demopoulos	Storage-stable glucosamine sulphate oral dosage forms and methods for their manufacture
EP0481214B1 (en) *	1990-09-14	1998-06-24	Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic	Prodrugs of phosphonates
JPH0825905B2 (ja) *	1990-11-20	1996-03-13	武田薬品工業株式会社	医薬固形組成物用安定化剤および安定化方法
HU9203780D0 (en) *	1991-12-12	1993-03-29	Sandoz Ag	Stabilized pharmaceutical products of hmg-coa reductase inhibitor and method for producing them
WO1994016693A1 (en) *	1993-01-19	1994-08-04	Warner-Lambert Company	Stable oral ci-981 formulation and process of preparing same
US5817336A (en) *	1993-04-02	1998-10-06	Orion-Yhtyma Oy	Composition containing selegiline
JP2974550B2 (ja) *	1993-06-01	1999-11-10	ビオフェルミン製薬株式会社	経口投与用固体組成物
US5919776A (en) *	1996-12-20	1999-07-06	Merck & Co., Inc.	Substituted aminoquinolines as modulators of chemokine receptor activity
JP2762998B2 (ja) *	1997-04-25	1998-06-11	武田薬品工業株式会社	医薬固形組成物用安定化剤および安定化方法
JPH114666A (ja) *	1997-06-17	1999-01-12	Otsuka Pharmaceut Co Ltd	マグネシウム補給発泡剤組成物
SI1256585T1 (en) *	1997-07-25	2005-02-28	Gilead Sciences, Inc.	Process for preparing 9-(2-(diethylphosphonomethoxy)ethyl)-adenine

1999
- 1999-12-10 TW TW088121700A patent/TWI230618B/zh not_active IP Right Cessation
- 1999-12-13 CO CO99077816A patent/CO5261557A1/es active IP Right Grant
- 1999-12-14 ES ES99967310T patent/ES2245130T3/es not_active Expired - Lifetime
- 1999-12-14 AT AT99967310T patent/ATE298576T1/de not_active IP Right Cessation
- 1999-12-14 NZ NZ511855A patent/NZ511855A/en not_active IP Right Cessation
- 1999-12-14 DE DE69926012T patent/DE69926012T2/de not_active Expired - Lifetime
- 1999-12-14 CA CA002355239A patent/CA2355239C/en not_active Expired - Lifetime
- 1999-12-14 BR BRPI9916820A patent/BRPI9916820B8/pt not_active IP Right Cessation
- 1999-12-14 JP JP2000587780A patent/JP4750946B2/ja not_active Expired - Lifetime
- 1999-12-14 KR KR1020017007531A patent/KR100624214B1/ko not_active Expired - Lifetime
- 1999-12-14 TR TR2001/01746T patent/TR200101746T2/xx unknown
- 1999-12-14 AU AU23613/00A patent/AU759869B2/en not_active Expired
- 1999-12-14 EP EP99967310A patent/EP1140114B1/en not_active Expired - Lifetime
- 1999-12-14 CN CNB998145289A patent/CN1202829C/zh not_active Expired - Lifetime
- 1999-12-14 WO PCT/US1999/029626 patent/WO2000035460A2/en not_active Ceased
- 1999-12-14 ID IDW00200101527A patent/ID30032A/id unknown
- 1999-12-14 AR ARP990106372A patent/AR021670A1/es active IP Right Grant
- 1999-12-14 CN CNB2005100659791A patent/CN100361664C/zh not_active Expired - Lifetime
- 1999-12-14 MY MYPI99005427A patent/MY126526A/en unknown

Also Published As

Publication number	Publication date
KR100624214B1 (ko)	2006-09-18
CN1682743A (zh)	2005-10-19
NZ511855A (en)	2003-07-25
CA2355239A1 (en)	2000-06-22
JP2002532429A (ja)	2002-10-02
AU2361300A (en)	2000-07-03
DE69926012D1 (de)	2005-08-04
EP1140114B1 (en)	2005-06-29
DE69926012T2 (de)	2006-05-04
BRPI9916820B8 (pt)	2023-04-25
CA2355239C (en)	2008-03-18
CO5261557A1 (es)	2003-03-31
BRPI9916820A2 (pt)	2001-10-30
ATE298576T1 (de)	2005-07-15
EP1140114A2 (en)	2001-10-10
HK1040488A1 (en)	2002-06-14
KR20010080765A (ko)	2001-08-22
TWI230618B (en)	2005-04-11
JP4750946B2 (ja)	2011-08-17
ES2245130T3 (es)	2005-12-16
MY126526A (en)	2006-10-31
CN100361664C (zh)	2008-01-16
AU759869B2 (en)	2003-05-01
BRPI9916820B1 (pt)	2018-04-03
TR200101746T2 (tr)	2001-12-21
CN1202829C (zh)	2005-05-25
CN1330547A (zh)	2002-01-09
WO2000035460A2 (en)	2000-06-22
AR021670A1 (es)	2002-07-31
WO2000035460A3 (en)	2000-11-09

Publication	Publication Date	Title
NO20012915D0 (no)	2001-06-13	Ny farmasöytisk formulering
ID24654A (id)	2000-07-27	Formulasi farmasi omeprazola
ID23299A (id)	2000-04-05	Formulasi-formulasi farmasi
DK1073417T3 (da)	2003-03-24	Farmaceutisk aerosolformulering
ID27415A (id)	2001-04-05	Komposisi farmaseutik
FIU20000164U0 (fi)	2000-04-11	Uusi farmaseuttinen formulaatio
ID28698A (id)	2001-06-28	Formulasi antiparasit
ID29635A (id)	2001-09-06	Formulasi mikrokapsul
ID29262A (id)	2001-08-16	Komposisi farmasi
DK1466615T3 (da)	2009-08-31	Farmaceutisk præparat
ID27201A (id)	2001-03-08	Komposisi farmasi
ID27655A (id)	2001-04-19	Formulasi mikrokapsul
ID30032A (id)	2001-11-01	Formulasi farmasi
IS2515B (is)	2009-06-15	Lyfjasamsetningar
AR025867A1 (es)	2002-12-18	Formulacion portasdora farmaceutica
EE200000330A (et)	2001-08-15	Farmatseutilised kompositsioonid
EP1124557A4 (en)	2002-08-07	Pharmaceutical composition
ID26215A (id)	2000-12-07	Komposisi farmasi
NO20004816D0 (no)	2000-09-26	Ny farmasøytisk formulering
NO994436D0 (no)	1999-09-13	Farmasöytiske sammensetninger
SE9803952D0 (sv)	1998-11-18	Pharmaceutical formulation
SE9600141D0 (sv)	1996-01-16	Pharmaceutical formulation
SE9800170D0 (sv)	1998-01-22	Formulation
SE9800766D0 (sv)	1998-03-09	Formulation
FI981567A0 (fi)	1998-07-07	Farmaseuttiset koostumukset